Free Trial

Choppy Rates As Equities Remain Buoyed

US TSYS SUMMARY

Tsy futures were back to mildly weaker after the closing bell, bid for rates evaporated late w/equities bouncing back toward late morning highs before settling in again (ESZ0 +49.0). Note, Dec 2-10Y futures extend session lows while long end outperforms. Choppy trade at best on mild volumes (TYZ <700k well after the close).

  • Late session chop in equities after AstraZeneca headline: "U.S. TRIAL STAYS ON HOLD PENDING U.S. PROBE: RTRS".
  • Decent pick-up in corporate issuance, $13B to price after more than $75B priced last week.
  • Early jump in 3M FRA/OIS by 7.0005 to 23.6005 high -- is tied to 3M Dec Eurodollar futures taking place of now expired Sep futures. Front roll was 16.500, but now appr 22.700 as it covers Dec futures and year end.
  • The 2-Yr yield is up 0.8bps at 0.135%, 5-Yr is up 1.1bps at 0.2627%, 10-Yr is up 0.8bps at 0.6739%, and 30-Yr is up 0.3bps at 1.4148%.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.